- Drugs
- Tuesday, 07 Jan 2020
Harvest Files Suit Against Falcon International, Inc.
Harvest Health & Recreation Inc. (CSE: HARV, OTCQX: HRVSF) ("Harvest"), a vertically integrated cannabis company with one of the largest and deepest footprints in the U.S., announced that yesterday Harvest filed suit against Falcon International, Inc. ("Falcon") requesting termination and rescission of the Merger Agreement ("Transaction") and return of money Harvest paid to Falcon under the Merger Agreement. As detailed in the Complaint, filed in U.S. Federal Court, District of Arizona, Harvest alleges that Falcon has failed to meet its legal obligations in multiple ways, including the failure to provide auditable financial records, which precludes Harvest from moving forward with the Transaction.
While Harvest remains committed to the long-term potential of legal cannabis sales in California, current market conditions make it difficult to operate profitably there today. If the Transaction does not close for any reason, including those enumerated in the Complaint, the company plans to remove the contribution attributable to Falcon from its 2020 pro forma guidance. Harvest expects overall 2020 pro forma profitability would improve without the revenue contribution from Falcon.
Related Industry Updates
Brazil Vitamin K2 Market is expected to reach US$ 9.81 million by 2028
Jun 09, 2023
Former Deputy Head of China's Drug Regulator Sentenced to 16 Years in Prison
Nov 15, 2019
COVID-19 Fallout Drives Major Increases for Driven's Online Cannabis Sales
Mar 17, 2020
Aphria Inc Launches Plant Positivity Social Impact Platform with Evergreen
Sep 19, 2019
Sanofi says COVID-19 vaccine will be available globally at the same time
May 15, 2020
Glioma Treatment Market is expected to reach US$ 8,291.3 million by 2030
Sep 18, 2023
Prostate Cancer Therapeutics Market is expected to grow US$ 28,425.27 million by 2030
Dec 12, 2023